Exchange: OTC·Updated 05:12 PM EDT

CURLFCuraleaf Holdings Inc

$9.35
$0.00
(0.00%)
Today
Closed $9.35
$0.0223
(0.24%)
After Hours
EarningsAug 5
Mkt Cap$3.06B
Vol69,177.00
News
all
press releases
Verano Advances U.S. Exchange Uplisting Plans: Time to Invest?
VRNO's reverse split and prior U.S. redomestication support potential exchange uplisting plans as the company expands stores and product offerings.
Zacks
News Placeholder
More News
News Placeholder
Curaleaf Prepares for US Exchange Uplisting: Time to Invest?
CURLF's reverse stock split and Delaware domestication plan signal preparation for a potential U.S. uplisting as revenue and international growth improve.
Zacks
News Placeholder
Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?
Here is how Cabaletta Bio, Inc. (CABA) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
Zacks
News Placeholder
Curaleaf Holdings, Inc. (CURLF) Q1 Earnings and Revenues Top Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +220.00% and +2.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Schedule III for Some, Not All: Understanding the DOJ's Cannabis Shift
DOJ narrows cannabis reform, shifting select marijuana products to Schedule III while leaving broader federal restrictions intact.
Zacks
News Placeholder
Curaleaf Launches Buyback Program: Time to Get Bullish on the Stock?
CURLF's $83M buyback lifts shares, but U.S. pricing pressure and rising losses cloud the outlook despite strong international growth momentum.
Zacks
News Placeholder
Cannabis Stock ACB Down 19% YTD: Should You Buy the Dip?
Aurora Cannabis stock has slid 19% YTD as competition and weak consumer cannabis weigh, but strong medical growth and rising margins could shape its next move.
Zacks
News Placeholder
Cannabis Operator VFF Stock Down 26% YTD: How to Play the Stock?
Village Farms' stock slides as U.S. headwinds and stiff competition weigh, but a 500% surge in international cannabis sales is reshaping its growth outlook.
Zacks
News Placeholder
Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?
TLRY posts mixed Q3 with revenue growth and narrowing losses, as strong cannabis and distribution gains offset beverage weakness and rising competition.
Zacks
News Placeholder
Cannabis Operator CRON Rises 46% in a Year: Time to Buy, Sell or Hold?
Cronos stock jumps 46% on strong international growth, margin expansion, and reform optimism; can the company sustain momentum amid rising competition?
Zacks
<
1
2
...
>

Advertisement|Remove ads.